Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A concentration-dependent analysis method for high density protein microarrays.

Ovidiu Marina1, Melinda A Biernacki, Vladimir Brusic

  • 1Cancer Vaccine Center and Division of Hematologic Neoplasia, Dana-Farber Cancer Institute, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Harvard Institutes of Medicine, Boston, MA 02115, USA.

Journal of Proteome Research
|April 9, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Publisher Correction: Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastoma.

Nature cancer·2026
Same author

Plant-based whole-food diets are feasible during auto-HCT and are associated with dose-dependent microbiome modulation.

Blood advances·2026
Same author

Publisher Correction: Single-cell epigenetic and transcriptomic states across the continuum of monoclonal B cell lymphocytosis to chronic lymphocytic leukemia.

Genome biology·2026
Same author

Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastoma.

Nature cancer·2026
Same author

Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti-PD-1 Therapy in Clear Cell Renal Cell Carcinoma: analyses of the HCRN GU16-260 trial.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Unfinished Business in Chronic Lymphocytic Leukemia: Translational and Clinical Priorities for a Cure.

Blood·2026
Same journal

From Method-Defined Signals to Reference Measurement Procedures: Two Decades of Mass Spectrometry-Based ProGRP Quantification.

Journal of proteome research·2026
Same journal

Proteomic Profiling of Extracellular Vesicle-Enriched Plasma Using Mag-Net for Biomarker Discovery in Pancreatic Ductal Adenocarcinoma.

Journal of proteome research·2026
Same journal

Computationally Efficient Bayesian Estimation of Graphical Networks for Omics Data.

Journal of proteome research·2026
Same journal

Hierarchy of MS-Based Evidence.

Journal of proteome research·2026
Same journal

Proteomic Profiling of Exosomes from HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma: Selective Cargo Packaging.

Journal of proteome research·2026
Same journal

Proteomic Analysis Identifies ATE1-Dependent Arginylation Dysregulation across Meningioma Grades.

Journal of proteome research·2026
See all related articles

A new concentration-dependent analysis (CDA) method improves protein microarray data interpretation. This approach enhances the discovery of disease biomarkers for cancer and autoimmune disorders.

Area of Science:

  • Proteomics
  • Biotechnology
  • Immunology

Background:

  • Protein microarray technology offers high-throughput screening for disease biomarkers.
  • Current analytical tools for interpreting protein microarray data are limited.
  • Accurate data analysis is crucial for identifying antibody targets in various diseases.

Purpose of the Study:

  • To develop and validate a novel analytical method for protein microarray data.
  • To address limitations in current high-throughput array data interpretation.
  • To enhance the discovery of serum antibody targets in cancer, autoimmunity, and infectious diseases.

Main Methods:

  • Developed a concentration-dependent analysis (CDA) method for normalizing protein microarray data.
  • Normalized data based on the concentration of spotted probes.

Related Experiment Videos

  • Compared CDA with existing analytical methods and validated findings experimentally.

    • Main Results:

    • The CDA method samples a unique data space, complementary to existing analyses.
    • Experimental validation confirmed 92% of hits identified by combining CDA with other tools.
    • CDA demonstrated robustness in identifying potential disease biomarkers.

    Conclusions:

    • The concentration-dependent analysis (CDA) is a valuable tool for protein microarray data.
    • CDA can serve as a preprocessing step or a stand-alone method for proteomic analysis.
    • This method supports accelerated biomarker discovery in clinical and research settings.